MedTrace Logo

Evidence For Fusion In Spine With Orthoss®

NCT03853356 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2025-09-10

No results posted yet for this study

Summary

This study aims to evaluate the performance and safety of the Orthoss® as a bone graft extender in lumbar spondylodesis involving 1-2 levels (L4-L5 and/or L5-S1).

Conditions

  • Lumbar Spondylolisthesis Involving L4-L5
  • Lumbar Spondylolisthesis Involving L5-S1
  • Lumbar Spinal Stenosis
  • Lumbar Disc Degeneration

Interventions

DEVICE

Orthoss

Orthoss® granules. Orthoss® granules mixed with local bone and pedicle bone marrow aspirate.

Sponsors & Collaborators

  • Geistlich Pharma AG

    lead INDUSTRY

Principal Investigators

  • Fabiana Martinelli · Geistlich Pharma AG

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-18
Primary Completion
2025-07-17
Completion
2027-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03853356 on ClinicalTrials.gov